QURE vs. DOCS
QURE (uniQure N.V.) and DOCS (Doximity, Inc.) are both stocks. Both are in the Healthcare sector — QURE in Biotechnology, DOCS in Health Information Services. Over the past 3 years, QURE returned 10.96%/yr vs -14.86%/yr for DOCS. At a 0.27 correlation, their price movements are largely independent.
Performance
QURE vs. DOCS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QURE achieves a 15.21% return, which is significantly higher than DOCS's -54.74% return.
QURE
- 1D
- 2.80%
- 1M
- -5.49%
- YTD
- 15.21%
- 6M
- 41.31%
- 1Y
- 72.42%
- 3Y*
- 10.96%
- 5Y*
- -5.23%
- 10Y*
- 11.46%
DOCS
- 1D
- 0.10%
- 1M
- -14.32%
- YTD
- -54.74%
- 6M
- -54.30%
- 1Y
- -64.81%
- 3Y*
- -14.86%
- 5Y*
- —
- 10Y*
- —
QURE vs. DOCS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
QURE uniQure N.V. | 15.21% | 35.50% | 160.86% | -70.14% | 9.31% | -30.80% |
DOCS Doximity, Inc. | -54.74% | -17.06% | 90.41% | -16.45% | -33.05% | 21.76% |
Correlation
The correlation between QURE and DOCS is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jun 24, 2021 | 0.27 |
The correlation between QURE and DOCS shifts across timeframes, from 0.11 (1 year) to 0.27 (all time), reflecting how their relationship changes across market environments.
Fundamentals
QURE:
$1.73B
DOCS:
$3.91B
QURE:
-$3.58
DOCS:
$0.98
QURE:
88.98
DOCS:
6.19
QURE:
11.58
DOCS:
4.11
QURE:
$18.09M
DOCS:
$644.86M
QURE:
$13.42M
DOCS:
$574.54M
QURE:
-$164.53M
DOCS:
$245.76M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QURE vs. DOCS — Risk / Return Rank
QURE
DOCS
QURE vs. DOCS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for uniQure N.V. (QURE) and Doximity, Inc. (DOCS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QURE | DOCS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.47 | ||
| Sortino ratioReturn per unit of downside risk | +4.95 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 0.72 | +0.73 |
| Calmar ratioReturn relative to maximum drawdown | 0.83 | -0.85 | +1.69 |
| Martin ratioReturn relative to average drawdown | 1.35 | -1.43 | +2.78 |
Loading charts...
Drawdowns
QURE vs. DOCS - Drawdown Comparison
The maximum QURE drawdown since its inception was -95.40%, which is greater than DOCS's maximum drawdown of -82.35%. Use the drawdown chart below to compare losses from any high point for QURE and DOCS.
Loading charts...
Drawdown Indicators
| QURE | DOCS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.40% | -82.35% | -13.05% |
Max Drawdown (1Y)Largest decline over 1 year | -87.21% | -76.03% | -11.18% |
Max Drawdown (3Y)Largest decline over 3 years | -87.21% | -78.34% | -8.87% |
Max Drawdown (5Y)Largest decline over 5 years | -90.11% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -95.40% | — | — |
Current DrawdownCurrent decline from peak | -66.46% | -80.36% | +13.90% |
Average DrawdownAverage peak-to-trough decline | -56.61% | -57.18% | +0.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 53.75% | 45.49% | +8.26% |
Volatility
QURE vs. DOCS - Volatility Comparison
The current volatility for uniQure N.V. (QURE) is 24.13%, while Doximity, Inc. (DOCS) has a volatility of 29.57%. This indicates that QURE experiences smaller price fluctuations and is considered to be less risky than DOCS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QURE | DOCS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.13% | 29.57% | -5.44% |
Volatility (6M)Calculated over the trailing 6-month period | 92.07% | 44.93% | +47.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 273.03% | 54.14% | +218.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 154.02% | 70.07% | +83.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 119.76% | 70.07% | +49.69% |
Dividends
QURE vs. DOCS - Dividend Comparison
Neither QURE nor DOCS has paid dividends to shareholders.
Financials
QURE vs. DOCS - Financials Comparison
This section allows you to compare key financial metrics between uniQure N.V. and Doximity, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
QURE and DOCS have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DOCS has higher volatility (29.57%) compared to QURE (24.13%). In terms of maximum drawdown, QURE dropped -95.40% vs DOCS's -82.35%.
QURE currently has the higher Sharpe Ratio (0.27 vs -1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QURE and DOCS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer